| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.4M | +79.6% |
| SG&A Expense | $6.0M | +2.5% |
| Operating Income | -$12.4M | -31.5% |
| Net Income | -$12.2M | -30.9% |
| EPS (Basic) | -$9.41 | -31.8% |
| EPS (Diluted) | -$9.41 | -31.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.7M | -66.0% |
| Total Assets | $3.7M | -66.0% |
| Current Liabilities | $2.4M | +33.0% |
| Total Liabilities | $2.4M | +33.0% |
| Stockholders' Equity | $1.3M | -85.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.9M | -49.3% |
| Financing Cash Flow | $3.5M | -69.9% |